T7212 |
Delavirdine mesylate
|
147221-93-0
|
99.75%
|
|
Delavirdine mesylate (BHAP-U 90152 (mesylate)) is a non-nucleoside reverse transcriptase inhibitor (NNRTI).
|
T0131 |
Cepharanthine
|
481-49-2
|
99.74%
|
|
Cepharanthine (NSC-623442), a biscoclaurine alkaloid, suppresses tumor necrosis factor (TNF)-α-mediated NFκB stimulation, plasma membrane lipid peroxidation and ...
|
T3199 |
PTACH
|
848354-66-5
|
99.74%
|
|
PTACH (Cpd 51) (NCH-51) is a SAHA-based inhibitor of human HDAC. It can potently inhibit the growth of various human Y cells (EC50: 1 to 10 μM).
|
T30047 |
Ancriviroc
|
370893-06-4
|
99.74%
|
|
Ancriviroc(CHEMBL336672), an imidoxime with strong antiretroviral activity, is a potent CCR5 inhibitor that can be used to study HIV.
|
T2329 |
Dolutegravir sodium
|
1051375-19-9
|
99.74%
|
|
Dolutegravir sodium (GSK-1349572A) salt(DTG; GSK1349572) is an HIV integrase inhibitor(IC50: 2.7 nM), modest activity against raltegravir-resistant signature mut...
|
T2332 |
Elvitegravir
|
697761-98-1
|
99.73%
|
|
Elvitegravir (JTK-303) is a Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor. The mechanism of action of elvitegravir is as an HIV Integrase Inhi...
|
T1284 |
Megestrol acetate
|
595-33-5
|
99.72%
|
|
Megestrol acetate (BDH1298) is a progestogen with actions and uses similar to those of the progestogens in general. Megestrol acetate also has anti-androgenic pr...
|
T30527 |
BMS-488043
|
452296-83-2
|
99.72%
|
|
BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) l...
|
T6098 |
Cabotegravir
|
1051375-10-0
|
99.71%
|
|
Cabotegravir (S/GSK1265744) (GSK744, GSK1265744) is a long-acting HIV integrase inhibitor and inhibits the HIV-1 integrase catalyzed strand transfer reaction (IC...
|
T67804 |
KM-023
|
1097628-00-6
|
99.70%
|
|
KM-023 is a new second-generation non-nucleoside reverse transcriptase inhibitor for the study of human immunodeficiency virus (HIV) type 1 infection.
|
T2324 |
Darunavir
|
206361-99-1
|
99.69%
|
|
Darunavir (TMC114) is an HIV PROTEASE INHIBITOR that is used in the treatment of AIDS and HIV INFECTIONS. Due to the emergence of ANTIVIRAL DRUG RESISTANCE when ...
|
T2556 |
Nandrolone decanoate
|
360-70-3
|
99.68%
|
|
Nandrolone decanoate (19-Nortestosterone decanoate) is the decanoate salt form of nandrolone, an anabolic steroid analog of testosterone with androgenic, anaboli...
|
T27260 |
Emivirine
|
149950-60-7
|
99.68%
|
|
Emivirine (MKC-442) is a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.
|
T0753 |
Salicylanilide
|
87-17-2
|
99.68%
|
|
Salicylanilide (2-Hydroxybenzanilide)s are a group of compounds with antiviral potency, antibacterial and antifungal activities.
|
TP1348 |
FC131 TFA (606968-52-9 free base)
|
842166-42-1
|
99.67%
|
|
FC131 TFA (606968-52-9 free base) (FC131 TFA) is an antagonist of CXCR4 that inhibits the binding of [125I] -sdf-1 to CXCR4(IC50 : 4.5 nM ), and has anti-hiv act...
|
T0100 |
Atazanavir sulfate
|
229975-97-7
|
99.67%
|
|
Atazanavir sulfate (BMS-232632 sulfate) is an azapeptide and HIV-PROTEASE INHIBITOR that is used in the treatment of HIV INFECTIONS and AIDS in combination with ...
|
T11074 |
Dolutegravir intermediate-1
|
1335210-23-5
|
99.67%
|
|
Dolutegravir intermediate-1 (1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid) is a new synthetic Dolutegravir in...
|
T67797 |
DDG-39
|
119555-47-4
|
99.66%
|
|
DDG-39 (1-(2,3-dideoxy-2-fluoropentofuranosyl)cytosine) possesses antiviral activity with potent and selective anti-HIV-1 and HBV activity in cell culture. The a...
|
T4578 |
Tipranavir
|
174484-41-4
|
99.66%
|
|
Tipranavir is a protease inhibitor that inhibits HIV-1 resistant to more than 1 protease inhibitor .Tipranavir effectively inhibits HIV-1 protease enzyme activit...
|
TN4673 |
(+)-Nortrachelogenin
|
61521-74-2
|
99.64%
|
|
(+)-Nortrachelogenin is a lignan isolated from Wikstroemia indica C.A. Meyer (Thymelaeaceae). (+)-Nortrachelogenin possesses antileukemic activity.
|